Cargando…

A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells

BACKGROUND: Osteosarcoma (OS) is one of the most difficult cancers to treat due to its resistance to chemotherapy. The essential role played by Mcl-1 in promoting chemoresistance has been observed in a variety of cancers, including OS, while the underlying mechanism remains unclear. METHODS: We inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, An-song, Yu, Hai-yang, Yang, Yan-lin, Xue, Fu-yao, Chen, Xia, Zhang, Yun, Zhou, Zi-yu, Zhang, Bin, Li, Lan, Sun, Chuan-zheng, Huang, Peng, Huang, Ju-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942534/
https://www.ncbi.nlm.nih.gov/pubmed/32021245
http://dx.doi.org/10.2147/OTT.S231125
_version_ 1783484726111109120
author Liu, An-song
Yu, Hai-yang
Yang, Yan-lin
Xue, Fu-yao
Chen, Xia
Zhang, Yun
Zhou, Zi-yu
Zhang, Bin
Li, Lan
Sun, Chuan-zheng
Huang, Peng
Huang, Ju-fang
author_facet Liu, An-song
Yu, Hai-yang
Yang, Yan-lin
Xue, Fu-yao
Chen, Xia
Zhang, Yun
Zhou, Zi-yu
Zhang, Bin
Li, Lan
Sun, Chuan-zheng
Huang, Peng
Huang, Ju-fang
author_sort Liu, An-song
collection PubMed
description BACKGROUND: Osteosarcoma (OS) is one of the most difficult cancers to treat due to its resistance to chemotherapy. The essential role played by Mcl-1 in promoting chemoresistance has been observed in a variety of cancers, including OS, while the underlying mechanism remains unclear. METHODS: We investigated the expression of Mcl-1 in 42 paired OS specimens obtained before and after adjuvant chemotherapy, and its correlation with clinicopathological characteristics. Loss and gain of function studies were performed to analyze the effects of Mcl-1 modulations on the chemosensitivity, and the mechanism involved in the deregulation of Mcl-1 in OS cells. RESULTS: In OS specimens, the expression of Mcl-1 was significantly upregulated after chemotherapy, and high Mcl-1 expression was associated with poorer overall survival and an increased recurrence rate. Furthermore, we demonstrated that chemotherapy-driven increased Mcl-1 decreased chemosensitivity by promoting tumour proliferation and inhibiting DNA damage. Moreover, Mcl-1 was found to be a direct target of miR-375 in OS cells. The knockdown of Mcl-1 phenocopied miR-375 downregulation, and the overexpression of miR-375 rescued the effects of cisplatin-induced DNA damage mediated by Mcl-1. CONCLUSION: Our data indicated that chemotherapy-driven increase in the expression of Mcl-1 plays a critical role in chemoresistance, and the intervention of the miR-375/Mcl-1 axis may offer a novel strategy to enhance chemosensitivity in OS treatment.
format Online
Article
Text
id pubmed-6942534
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69425342020-02-04 A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells Liu, An-song Yu, Hai-yang Yang, Yan-lin Xue, Fu-yao Chen, Xia Zhang, Yun Zhou, Zi-yu Zhang, Bin Li, Lan Sun, Chuan-zheng Huang, Peng Huang, Ju-fang Onco Targets Ther Original Research BACKGROUND: Osteosarcoma (OS) is one of the most difficult cancers to treat due to its resistance to chemotherapy. The essential role played by Mcl-1 in promoting chemoresistance has been observed in a variety of cancers, including OS, while the underlying mechanism remains unclear. METHODS: We investigated the expression of Mcl-1 in 42 paired OS specimens obtained before and after adjuvant chemotherapy, and its correlation with clinicopathological characteristics. Loss and gain of function studies were performed to analyze the effects of Mcl-1 modulations on the chemosensitivity, and the mechanism involved in the deregulation of Mcl-1 in OS cells. RESULTS: In OS specimens, the expression of Mcl-1 was significantly upregulated after chemotherapy, and high Mcl-1 expression was associated with poorer overall survival and an increased recurrence rate. Furthermore, we demonstrated that chemotherapy-driven increased Mcl-1 decreased chemosensitivity by promoting tumour proliferation and inhibiting DNA damage. Moreover, Mcl-1 was found to be a direct target of miR-375 in OS cells. The knockdown of Mcl-1 phenocopied miR-375 downregulation, and the overexpression of miR-375 rescued the effects of cisplatin-induced DNA damage mediated by Mcl-1. CONCLUSION: Our data indicated that chemotherapy-driven increase in the expression of Mcl-1 plays a critical role in chemoresistance, and the intervention of the miR-375/Mcl-1 axis may offer a novel strategy to enhance chemosensitivity in OS treatment. Dove 2019-12-31 /pmc/articles/PMC6942534/ /pubmed/32021245 http://dx.doi.org/10.2147/OTT.S231125 Text en © 2019 Liu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, An-song
Yu, Hai-yang
Yang, Yan-lin
Xue, Fu-yao
Chen, Xia
Zhang, Yun
Zhou, Zi-yu
Zhang, Bin
Li, Lan
Sun, Chuan-zheng
Huang, Peng
Huang, Ju-fang
A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
title A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
title_full A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
title_fullStr A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
title_full_unstemmed A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
title_short A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
title_sort chemotherapy-driven increase in mcl-1 mediates the effect of mir-375 on cisplatin resistance in osteosarcoma cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942534/
https://www.ncbi.nlm.nih.gov/pubmed/32021245
http://dx.doi.org/10.2147/OTT.S231125
work_keys_str_mv AT liuansong achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT yuhaiyang achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT yangyanlin achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT xuefuyao achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT chenxia achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT zhangyun achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT zhouziyu achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT zhangbin achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT lilan achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT sunchuanzheng achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT huangpeng achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT huangjufang achemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT liuansong chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT yuhaiyang chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT yangyanlin chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT xuefuyao chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT chenxia chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT zhangyun chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT zhouziyu chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT zhangbin chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT lilan chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT sunchuanzheng chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT huangpeng chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells
AT huangjufang chemotherapydrivenincreaseinmcl1mediatestheeffectofmir375oncisplatinresistanceinosteosarcomacells